Stocks and Investing Stocks and Investing
Fri, September 13, 2024

Anupam Rama Maintained (APLS) at Buy with Decreased Target to $57 on, Sep 13th, 2024


Published on 2024-10-28 14:14:54 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Decreased Target from $64 to $57 on, Sep 13th, 2024.

Anupam has made no other calls on APLS in the last 4 months.



There are 9 other peers that have a rating on APLS. Out of the 9 peers that are also analyzing APLS, 3 agree with Anupam's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $41 on, Friday, August 9th, 2024
  • Biren Amin of "Piper Sandler" Initiated at Hold and Held Target at $46 on, Friday, May 31st, 2024
  • Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $48 on, Thursday, May 23rd, 2024


These are the ratings of the 6 analyists that currently disagree with Anupam


  • Colleen Kusy of "Baird" Maintained at Buy with Increased Target to $96 on, Friday, August 9th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $83 on, Friday, August 9th, 2024
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $85 on, Friday, August 9th, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $74 on, Friday, August 9th, 2024
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $83 on, Friday, August 2nd, 2024
  • Akash Tewari of "Jefferies" Maintained at Strong Buy and Held Target at $80 on, Wednesday, July 31st, 2024
Contributing Sources